Security News
FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars
UnknownApr 23, 2026(12 days ago)
FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars
The U.S. Food and Drug Administration (“FDA”) recently released its congressional justification for the 2027 Fiscal Year budget. Overall, the FDA proposed a total budget of $7.2 billion, an overall increase of 3.3% above the 2026 Fiscal Year enacted level.... By: Goodwin
Related News
Rare appeal may shed light on compensable time for remote employees
Unknownin about 12 hours
CFPB Finalizes New 1071 Small Business Lending Rule – Key Takeaways
Unknownabout 2 hours ago
Delaware Courts Sharpen Focus on Earn Outs: Review of Recent Case Law and Practical Guidance for Dealmakers
Unknownabout 2 hours ago